 | • レポートコード：QYR9N7490 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、リソソーム蓄積症治療薬のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、幹細胞療法、基板削減療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・リソソーム蓄積症治療薬の世界市場規模 ・主要企業別市場シェア ・リソソーム蓄積症治療薬の世界市場規模：種類別（酵素補充療法、幹細胞療法、基板削減療法、その他） ・リソソーム蓄積症治療薬の世界市場規模：用途別（病院、診療所、その他） ・リソソーム蓄積症治療薬のアメリカ市場規模（種類別、用途別） ・リソソーム蓄積症治療薬のヨーロッパ市場規模（種類別、用途別） ・リソソーム蓄積症治療薬の中国市場規模（種類別、用途別） ・リソソーム蓄積症治療薬の日本市場規模（種類別、用途別） ・リソソーム蓄積症治療薬の東南アジア市場規模（種類別、用途別） ・リソソーム蓄積症治療薬のインド市場規模（種類別、用途別） ・リソソーム蓄積症治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・リソソーム蓄積症治療薬の世界市場予測（2019年-2025年） ・リソソーム蓄積症治療薬の地域別市場予測（2019年-2025年） ... |
Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells.The Gaucher’s Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market.
Europe is estimated to be the dominant market in the global lysosomal storage diseases therapeutics market in 2017.
North America is expected to be the second most lucrative market in the global lysosomal storage diseases therapeutics market over the forecast period.
In 2018, the global Lysosomal Storage Diseases Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Lysosomal Storage Diseases Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lysosomal Storage Diseases Therapeutics development in United States, Europe and China.
The key players covered in this study
Shire
Pfizer
Sanofi
BioMarin Pharmaceutical
Actelion Ltd
Raptor Pharmaceutical
Protalix Biotherapeutics
Amicus Therapeutics
Market segment by Type, the product can be split into
Enzyme Replacement Therapy
Stem Cell Therapy
Substrate Reduction Therapy
Other
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Lysosomal Storage Diseases Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Lysosomal Storage Diseases Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Lysosomal Storage Diseases Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Enzyme Replacement Therapy
1.4.3 Stem Cell Therapy
1.4.4 Substrate Reduction Therapy
1.4.5 Other
1.5 Market by Application
1.5.1 Global Lysosomal Storage Diseases Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Lysosomal Storage Diseases Therapeutics Market Size
2.2 Lysosomal Storage Diseases Therapeutics Growth Trends by Regions
2.2.1 Lysosomal Storage Diseases Therapeutics Market Size by Regions (2014-2025)
2.2.2 Lysosomal Storage Diseases Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Lysosomal Storage Diseases Therapeutics Market Size by Manufacturers
3.1.1 Global Lysosomal Storage Diseases Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Lysosomal Storage Diseases Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lysosomal Storage Diseases Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Lysosomal Storage Diseases Therapeutics Key Players Head office and Area Served
3.3 Key Players Lysosomal Storage Diseases Therapeutics Product/Solution/Service
3.4 Date of Enter into Lysosomal Storage Diseases Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Lysosomal Storage Diseases Therapeutics Market Size by Type (2014-2019)
4.2 Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Lysosomal Storage Diseases Therapeutics Market Size (2014-2019)
5.2 Lysosomal Storage Diseases Therapeutics Key Players in United States
5.3 United States Lysosomal Storage Diseases Therapeutics Market Size by Type
5.4 United States Lysosomal Storage Diseases Therapeutics Market Size by Application
6 Europe
6.1 Europe Lysosomal Storage Diseases Therapeutics Market Size (2014-2019)
6.2 Lysosomal Storage Diseases Therapeutics Key Players in Europe
6.3 Europe Lysosomal Storage Diseases Therapeutics Market Size by Type
6.4 Europe Lysosomal Storage Diseases Therapeutics Market Size by Application
7 China
7.1 China Lysosomal Storage Diseases Therapeutics Market Size (2014-2019)
7.2 Lysosomal Storage Diseases Therapeutics Key Players in China
7.3 China Lysosomal Storage Diseases Therapeutics Market Size by Type
7.4 China Lysosomal Storage Diseases Therapeutics Market Size by Application
8 Japan
8.1 Japan Lysosomal Storage Diseases Therapeutics Market Size (2014-2019)
8.2 Lysosomal Storage Diseases Therapeutics Key Players in Japan
8.3 Japan Lysosomal Storage Diseases Therapeutics Market Size by Type
8.4 Japan Lysosomal Storage Diseases Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size (2014-2019)
9.2 Lysosomal Storage Diseases Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size by Type
9.4 Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size by Application
10 India
10.1 India Lysosomal Storage Diseases Therapeutics Market Size (2014-2019)
10.2 Lysosomal Storage Diseases Therapeutics Key Players in India
10.3 India Lysosomal Storage Diseases Therapeutics Market Size by Type
10.4 India Lysosomal Storage Diseases Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Lysosomal Storage Diseases Therapeutics Market Size (2014-2019)
11.2 Lysosomal Storage Diseases Therapeutics Key Players in Central & South America
11.3 Central & South America Lysosomal Storage Diseases Therapeutics Market Size by Type
11.4 Central & South America Lysosomal Storage Diseases Therapeutics Market Size by Application
12 International Players Profiles
12.1 Shire
12.1.1 Shire Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lysosomal Storage Diseases Therapeutics Introduction
12.1.4 Shire Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
12.1.5 Shire Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lysosomal Storage Diseases Therapeutics Introduction
12.2.4 Pfizer Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lysosomal Storage Diseases Therapeutics Introduction
12.3.4 Sanofi Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 BioMarin Pharmaceutical
12.4.1 BioMarin Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lysosomal Storage Diseases Therapeutics Introduction
12.4.4 BioMarin Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
12.4.5 BioMarin Pharmaceutical Recent Development
12.5 Actelion Ltd
12.5.1 Actelion Ltd Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lysosomal Storage Diseases Therapeutics Introduction
12.5.4 Actelion Ltd Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
12.5.5 Actelion Ltd Recent Development
12.6 Raptor Pharmaceutical
12.6.1 Raptor Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lysosomal Storage Diseases Therapeutics Introduction
12.6.4 Raptor Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
12.6.5 Raptor Pharmaceutical Recent Development
12.7 Protalix Biotherapeutics
12.7.1 Protalix Biotherapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lysosomal Storage Diseases Therapeutics Introduction
12.7.4 Protalix Biotherapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
12.7.5 Protalix Biotherapeutics Recent Development
12.8 Amicus Therapeutics
12.8.1 Amicus Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lysosomal Storage Diseases Therapeutics Introduction
12.8.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
12.8.5 Amicus Therapeutics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Lysosomal Storage Diseases Therapeutics Key Market Segments
Table Key Players Lysosomal Storage Diseases Therapeutics Covered
Table Global Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size Market Share by Type 2014-2025
Figure Enzyme Replacement Therapy Figures
Table Key Players of Enzyme Replacement Therapy
Figure Stem Cell Therapy Figures
Table Key Players of Stem Cell Therapy
Figure Substrate Reduction Therapy Figures
Table Key Players of Substrate Reduction Therapy
Figure Other Figures
Table Key Players of Other
Table Global Lysosomal Storage Diseases Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Lysosomal Storage Diseases Therapeutics Report Years Considered
Table Global Lysosomal Storage Diseases Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Share by Regions 2014-2019
Figure Global Lysosomal Storage Diseases Therapeutics Market Share by Regions 2014-2019
Figure Global Lysosomal Storage Diseases Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Lysosomal Storage Diseases Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Lysosomal Storage Diseases Therapeutics Market Share by Manufacturers in 2018
Table Global Lysosomal Storage Diseases Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lysosomal Storage Diseases Therapeutics Product/Solution/Service
Table Date of Enter into Lysosomal Storage Diseases Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Size Share by Type (2014-2019)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Size Share by Application (2014-2019)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Lysosomal Storage Diseases Therapeutics Revenue Market Share by Application in 2018
Figure United States Lysosomal Storage Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Lysosomal Storage Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Lysosomal Storage Diseases Therapeutics Market Share (2018-2019)
Table United States Lysosomal Storage Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Lysosomal Storage Diseases Therapeutics Market Share by Type (2014-2019)
Table United States Lysosomal Storage Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Lysosomal Storage Diseases Therapeutics Market Share by Application (2014-2019)
Figure Europe Lysosomal Storage Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Lysosomal Storage Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Lysosomal Storage Diseases Therapeutics Market Share (2018-2019)
Table Europe Lysosomal Storage Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Lysosomal Storage Diseases Therapeutics Market Share by Type (2014-2019)
Table Europe Lysosomal Storage Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Lysosomal Storage Diseases Therapeutics Market Share by Application (2014-2019)
Figure China Lysosomal Storage Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Lysosomal Storage Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Lysosomal Storage Diseases Therapeutics Market Share (2018-2019)
Table China Lysosomal Storage Diseases Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Lysosomal Storage Diseases Therapeutics Market Share by Type (2014-2019)
Table China Lysosomal Storage Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Lysosomal Storage Diseases Therapeutics Market Share by Application (2014-2019)
Figure Japan Lysosomal Storage Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Lysosomal Storage Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Lysosomal Storage Diseases Therapeutics Market Share (2018-2019)
Table Japan Lysosomal Storage Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Lysosomal Storage Diseases Therapeutics Market Share by Type (2014-2019)
Table Japan Lysosomal Storage Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Lysosomal Storage Diseases Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lysosomal Storage Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lysosomal Storage Diseases Therapeutics Market Share (2018-2019)
Table Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Lysosomal Storage Diseases Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Lysosomal Storage Diseases Therapeutics Market Share by Application (2014-2019)
Figure India Lysosomal Storage Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Lysosomal Storage Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Lysosomal Storage Diseases Therapeutics Market Share (2018-2019)
Table India Lysosomal Storage Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Lysosomal Storage Diseases Therapeutics Market Share by Type (2014-2019)
Table India Lysosomal Storage Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Lysosomal Storage Diseases Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Lysosomal Storage Diseases Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lysosomal Storage Diseases Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lysosomal Storage Diseases Therapeutics Market Share (2018-2019)
Table Central & South America Lysosomal Storage Diseases Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Lysosomal Storage Diseases Therapeutics Market Share by Type (2014-2019)
Table Central & South America Lysosomal Storage Diseases Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Lysosomal Storage Diseases Therapeutics Market Share by Application (2014-2019)
Table Shire Company Details
Table Shire Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019) (Million US$)
Figure Shire Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
Table Shire Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table BioMarin Pharmaceutical Company Details
Table BioMarin Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)(Million US$)
Figure BioMarin Pharmaceutical Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
Table BioMarin Pharmaceutical Recent Development
Table Actelion Ltd Company Details
Table Actelion Ltd Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Actelion Ltd Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
Table Actelion Ltd Recent Development
Table Raptor Pharmaceutical Company Details
Table Raptor Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Raptor Pharmaceutical Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
Table Raptor Pharmaceutical Recent Development
Table Protalix Biotherapeutics Company Details
Table Protalix Biotherapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Protalix Biotherapeutics Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
Table Protalix Biotherapeutics Recent Development
Table Amicus Therapeutics Company Details
Table Amicus Therapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2014-2019)(Million US$)
Figure Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2014-2019)
Table Amicus Therapeutics Recent Development
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Lysosomal Storage Diseases Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size Share by Regions in 2025
Figure United States Lysosomal Storage Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lysosomal Storage Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Lysosomal Storage Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lysosomal Storage Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Lysosomal Storage Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lysosomal Storage Diseases Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size by Product (2019-2025)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size by Product in 2025
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2019-2025)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のリソソーム蓄積症（LSD）市場：市場規模・現状・予測 Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Dis…- 世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測 Lysosomal acid lipase deficiency (LAAL) is an autosomal recessive genetic disorder caused due to mutation in LIPE (Lipase E) gene which encodes the lysosomal acid lipase proteins on chromosome 10q23.31.In terms of region, due to high prevalence of lysosomal acid lipase deficiency disease, Europe and…
- 世界の肝疾患治療薬市場：市場規模・現状・予測 In 2018, the global Liver Diseases Therapeutics Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Liver Diseases Therapeutics Drugs status, future forecast, growth opportunity, key market a…
- 世界のナノセラピー市場：市場規模・現状・予測 Nanotherapy is a branch of nanomedicine that involves using nanoparticles to deliver a drug to a given target location in the body so as to treat the disease through a process known as targeting.Much of the research in nanotherapy has been largely directed towards cancer therapy. One of the biggest …
- 世界のファージ療法市場：市場規模・現状・予測 Phage therapy or viral phage therapy is the therapeutic use of bacteriophages to treat pathogenic bacterial infections.[1] Phage therapy has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.In 2018, the global Phage Therapy market size was xx mi…